Induction of Remission in Active Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis With Mycophenolate Mofetil in Patients Who Cannot Be Treated With Cyclophosphamide

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.2006.060301
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Anti-Neutrophil Cytoplasmic Antibody-Associated Paraneoplastic Vasculitis.

Postgraduate Medical Journal
Medicine
1994English

Animal Models of Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis

Kidney International
Nephrology
1998English

Propylthiouracil Induced Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis With Skin Lesions and Granulocytopenia

Endocrine Abstracts
2015English

Perinuclear Anti Neutrophil Cytoplasmic Antibody Vasculitis With Nonspecific Muscle Pain

International Journal of Research in Medical Sciences
2020English

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2010English

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Kidney International Reports
Nephrology
2018English

Health-Related Quality of Life in Patients With Newly Diagnosed Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Arthritis Care and Research
Rheumatology
2011English

Deep Vein Thrombosis as a Rare Presentation in a Female With Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis

Archives of Rheumatology
Rheumatology
2017English

Relationship Between Immunosuppressive Therapy and the Development of Infectious Complications Among Patients With Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single-Center, Retrospective Observational Study

Cureus
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy